Zhejiang Zonebanner Jiuzhou Imp. & Exp. Co.,Ltd.
Home Introduction Products Asymmetric Catalyst Order Contact us
 
 
Asymmetric Catalyst
Lithium battery materials
Active Pharmaceutical Ingredients
Intermediates
 
 
Gabapentin Hydrochloride
Enrofloxacin Hydrochloride
Ciprofloxacin Hydrochloride
Pioglitazone Hydrochloride
Terbinafine Hydrochloride
Fluoxetine Hydrochloride
Fluoxetine hydrochloride intermediate
Clopidogrel
Imatinib Intermediate
Telmisartan Intermediate
Gefitinib Intermediate
Acyclovir intermediate
Erlotinib Intermediate
Lapatinib Intermediate
Atazanavir Intermediate
Sitagliptin intermediate
 
 
Products
 
Chiral Spiro Ligands for Asymmetric Catalyst>>
Chiral Spiro Ligands for Asymmetric Catalyst

JiuZhou No.

Chemical Name

Structure Formula 

[α]D20

CAS Reg.No

Acronym

M.P. ℃

Abs. Config.

MF, MW

Purity HPLC

JZ-S001-1

N-Dimethyl-[(R)-1,1'-spirobiindane-7,7'diyl]phosphoramidite

+505
(c 0.5,
CH2Cl2)

[443965-14-8]

(R)-SIPHOS

95-96

( R )

C19H20NO2P
FW: 325.34

≥98%

JZ-S001-2

N-Dimethyl-[(S)-1,1'-spirobiindane-7,7'-diyl]phosphoramidite

-502
(c 0.5,
CH2Cl2)

[443965-10-4]

(S)-SIPHOS

95-96

( S )

C19H20NO2P
FW: 325.34

≥98%

JZ-S002-1

Phenyl-[(R)-1,1'-spirobiindane-7,7'-diyl]-phosphite

+216
(c 0.5,
CH2Cl2)

[656233-53-3]

(R)-ShiP

104-105

( R )

C23H19O3P
FW: 374.37

≥98%

JZ-S002-2

Phenyl-[(S)-1,1'-spirobiindane-7,7'-diyl]-phosphite

-215
(c 0.51,
CH2Cl2)

[885701-71-3]

(S)-ShiP

104-105

( S )

C23H19O3P
FW: 374.37

≥98%

JZ-S003-1

N-Di[(R)-1-phenylethyl]-[(R)-1,1'-spirobiindane-7,7'-diyl]-phosphoramidite

+300
(c 1.0,
CH2Cl2)

[500997-69-3]

(Ra,R,R)-SIPHOS-PE

98-100

( Ra,R,R )

C33H32NO2P
FW: 505.59

≥98%

JZ-S003-2

N-Di[(R)-1-phenylethyl]-[(S)-1,1'-spirobiindane-7,7'-diyl]-phosphoramidite

-63.5
(c 1.0,
CH2Cl2)

[500997-70-6]

(Sa,R,R)-SIPHOS-PE

99-101

( Sa,R,R )

C33H32NO2P
FW: 505.59

≥98%

JZ-S004-1

(R)–7,7'-bis(diphenylphosphino)-1,1'-spirobiindane

+207
(c 0.5,
CH2Cl2)

 [917377-74-3 ]

(R)-SDP

200-202

( R )

C41H34P2
FW: 588.66

≥97%

JZ-S004-2

(S)–7,7'-bis(diphenylphosphino)-1,1'-spirobiindane

-203
(c 0.5,
CH2Cl2)

[528521-86-0 ]

(S)-SDP

206-208

( S )

C41H34P2
FW: 588.66

≥97%

JZ-S005-1

(R)–7,7'-Bis[di(p-methylphenyl)phosphino]-1,1'-spirobiindane

+212
(c 0.53,
CH2Cl2)

[528521-87-1 ]

(R)-Tol-SDP

150-152

( R )

C45H42P2
FW: 644.76

≥97%

JZ-S005-2

(S)–7,7'-Bis[di(p-methylphenyl)phosphino]-1,1'-spirobiindane

-221
(c 0.54,
CH2Cl2)

[817176-80-0 ]

(S)-Tol-SDP

150-152

( S )

C45H42P2
FW: 644.76

≥97%

JZ-S006-1

(R)–7,7'-Bis[di(3,5-dimethylphenyl)phosphino]-1,1'-spirobiindane

+87.5
(c 0.53,
CH2Cl2)

[917377-75-4 ]

(R)-Xyl-SDP

Oil

( R )

C49H50P2
FW: 700.87

≥97%

JZ-S006-2

(S)–7,7'-Bis[di(3,5-dimethylphenyl)phosphino]-1,1'-spirobiindane

-83
(c 0.53,
CH2Cl2)

[528521-89-3 ]

(S)-Xyl-SDP

Oil

( S )

C49H50P2
FW: 700.87

≥97%

JZ-S007-1

(R)-O,O'-[7,7'-(1,1'-spirobiindan)]-tert-butylphosphonite

+456
(c 1.2,
CH2Cl2)

 

(R)-FuP-tBu

 

( R )

C21H23O2P
FW: 338.38

≥97%
≥99%EE

JZ-S007-2

(S)-O,O'-[7,7'-(1,1'-spirobiindan)]-tert-butylphosphonite

-456
(c 1.2,
CH2Cl2)

[912457-08-0]

(S)-FuP-tBu

 

( S )

C21H23O2P
FW: 338.38

≥97%
≥99%EE

JZ-S008-1

(R)-dimethylene-[7,7'-(1,1'-spiroindan)]-phenylphospholane

[α]D21:+6
(c 0.5,
CH2Cl2)

[856407-37-9]

(R)-SITCP

148-149

( R )

C25H23P
FW: 354.42

≥97%
≥99%EE

JZ-S008-2

(S)-dimethylene-[7,7'-(1,1'-spiroindan)]-phenylphospholane

[α]D21:-6
(c 0.5,
CH2Cl2)

[885701-78-0]

(S)-SITCP

148-149

( S )

C25H23P
FW: 354.42

≥97%
≥99%EE

JZ-S009-1

(Ra,S)-7-[4-(Benzyl)oxazol-2-yl]-7'-diphenylphosphinyl-1,1'-spirobiinane

 

 

(R,S)-Ph-Bn-SIPHOX

98-100

( Ra,S )

C39H34NOP
FW: 563.67

≥97%
≥99%EE

JZ-S009-2

(Sa,S)-7-[4-(Benzyl)oxazol-2-yl]-7'-diphenylphosphinyl-1,1'-spirobiinane

-227.0
(c 0.5,
CH2Cl2)

[913829-88-6]

(Sa,S)-Ph-Bn-SIPHOX

164-166

( Sa,S )

C39H34NOP
FW: 563.67

≥97%
≥99%EE

JZ-S010-1

(S,S)-7-[4-(Benzyl)oxazol-2-yl]-7'-di(3,5-ditertbutylphenyl)phosphinyl-1,1'- spirobiindane

[α]D25:
-185.6
(c 0.5,
CH2Cl2)

[1040274-10-9]

(S,S)-DTB-Bn-SIPHOX

159-161

(S,S)

C55H66NOP
FW: 788.09

≥97%
≥99%EE

JZ-S011-1

(S)-7-(4,5-Dihydrooxazol-2-yl)-7'-di(3,5-ditertbutylphenyl)phosphino-1,1'- spirobiinane

[α]D25:
-184.4
(c 0.5,
CH2Cl2)

[1040274-18-7]

(S)-DTB-SIPHOX

229-231

( S )

C48H60NOP
FW: 697.97

≥97%
≥99%EE

JZ-S012-1

(Sa,S)-7-[4-(Benzyl)oxazol-2-yl]-7-di(3,5-dimethylphenyl)phosphinyl-1,1- spirobiinane

[α]D24:
-196.8
(c 0.51,
CH2Cl2)

[913829-90-0]

(Sa,S)-Xyl-Bn-SIPHOX

Oil

( Sa,S )

C43H42NOP
FW: 619.77

≥97%
≥99%EE

JZ-S013-1

(Sa,S,S)-7,7'-bis(4'-phenyloxazol-2-yl)-1,1'-spirobiindane

-322
(c 0.5,
CH2Cl2)

[940880-69-3]

(Sa,S,S)-SpiroBOX

167-169

(Sa,S,S)

C35H30N2O2
FW: 510.62

≥97%

JZ-S013-2

(Ra,S,S)-7,7'-bis(4'-phenyloxazol-2-yl)-1,1'-spirobiindane

+93
(c 0.5,
CH2Cl2)

[890090-21-8]

(Ra,S,S)-SpiroBOX

130-132

(Ra,S,S)

C35H30N2O2
FW: 510.62

≥97%

 
 
Copyright(C)2009,ZhejiangZonebanner Jiuzhou Imp. & Exp. Co.,Ltd.All Rights Reserved. 浙ICP备05016231号
 Supported by ChemNet ChinaChemNet Toocle Copyright Notice